New York Pharma Forum Symposium Explores Novel Biopharma Investment and Partnership Strategies

Published: Dec 12, 2012

NEW YORK--(BUSINESS WIRE)--The biopharma industry faces significant challenges: diminishing capital for early-stage drug development, an uptick in drug patent expirations and efforts by payors to reduce reimbursement. To address these hurdles, industry leaders should consider new strategies to collaborate with academia, nonprofit organizations and industry peers. These were key conclusions at New York Pharma Forum’s (NYPF) 23rd Annual General Assembly in New York on December 7th.

Back to news